NCT04659538 - The CAPTIS® Study - Embolic Protection in TAVR | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

May 3, 2022

Study Completion Date

May 3, 2022

Conditions

Transcatheter Aortic Valve Replacement

Interventions

DEVICE

CAPTIS Embolic Protection device

The CAPTIS Embolic Protection device will be deployed during standard of care TAVR procedure. The device's safety will be assessed up to one month post procedure. The device's technical performance and feasibility to capture and remove debris during the procedure will be evaluated.

Trial Locations (3)

5822012

Wolfson Medical Center, Holon

Unknown

Rabin Medical Center, Petah Tikva

Sheba Medical Center, Ramat Gan